Country Report
Jan 2021
The emergence of the pandemic and initial stages of the lockdown resulted in stockpiling of perceived essential medicines, mainly in terms of preparation in case consumers became infected. This resulted in a notable upturn in demand for a number of ...
Country Report
Jan 2021
Cough, cold and allergy (hay fever) remedies was already enjoying strong demand prior to the outbreak of COVID-19, with consumers typically self-medicating against mild symptoms of cold and flu. With many of the symptoms of COVID-19 being similar to ...
Country Report
Jan 2021
Sales of cough/cold remedies benefited from the seasonal common cold and flu outbreak during the winter of 2019/2020, with this then leading into a spike in demand following the outbreak of COVID-19. When it comes to the common cold and flu many ...
Country Report
Jan 2021
Products designed to treat the symptoms of cold and flu benefited from the outbreak of COVID-19 in Austria, with many households stockpiling these products as a precaution. Many people have also become more sensitive turning to cough, cold and ...
Country Report
Dec 2020
The emergence of COVID-19 in Germany has had a fairly positive effect on demand for cough, cold and allergy (hay fever) remedies in 2020 as consumers wanted to feel secure about being able to treat themselves at home when suffering from various cold ...
Country Report
Nov 2020
The outbreak of COVID-19 in 2020 has driven demand for cough, cold and allergy remedies, with consumers seeking products to alleviate the symptoms of the virus. Cough remedies, combination cough, cold and allergy, oral and nasal decongestants are ...
Country Report
Nov 2020
Although cough, cold and allergy (hay fever) remedies saw strong current value growth during most of the review period, in 2020 the rate of growth is expected to increase as a result of COVID-19. In the first half of the year, consumers stockpiled as...
Country Report
Nov 2020
In 2020, cough, cold and allergy (hay fever) remedies is expected to see much higher current value growth than in the previous year. This is mostly because the COVID-19 outbreak fuelled high demand for cough remedies, paediatric cough/cold remedies, ...
Country Report
Nov 2020
The COVID-19 outbreak resulted in consumers becoming more conscious of health, and adopting more effective measures to eliminate flu and cold symptoms. This led to increased demand for cough, cold and allergy remedies, particularly prior to the ...
Country Report
Nov 2020
In 2020, cough, cold and allergy (hay fever) remedies is expected to see higher current value growth than in the previous year. Although sales of such products increased significantly during panic-buying in March and April due to COVID-19, demand saw...
Country Report
Nov 2020
Cough, cold and allergy (hay fever) remedies is expected to be largely unaffected by COVID-19, with similar healthy double-digit value growth as 2019. However, part of this growth in 2020 is driven by inflation as a result of the economic effect of ...
Country Report
Nov 2020
There was a strong upsurge in demand for cough, cold and allergy (hay fever) remedies in the first quarter of 2020 at the peak of the pandemic. In the second quarter demand normalised as consumers went through their stock of cough, cold and allergy ...
Country Report
Nov 2020
COVID-19 was a mixed blessing for cough, cold and allergy (hay fever) remedies in Latvia in 2020. Each year the sales performance for cough, cold and allergy (hay fever) remedies is highly dependent on the incidence of seasonal malaises. Therefore, ...
Country Report
Nov 2020
Value sales of cough, cold and allergy (hay fever) remedies increased in early 2020 as a result of health-conscious consumers stocking up on medicines in case they were needed to combat the symptoms of the COVID-19 virus. Although demand has ...
Country Report
Nov 2020
Panic and fear caused by the outbreak of COVID-19 has provoked Moroccan consumers to stockpile many products in cough, cold and allergy (hay fever) remedies. In most cases, consumer decision making was based on future precaution rather than specific ...
Country Report
Nov 2020
The COVID-19 pandemic has strongly impacted current retail value sales of cough, cold and allergy products in 2020. Stockpiling occurred at the start of lockdown as consumers made sure they had large enough supplies of these products for themselves ...
Country Report
Nov 2020
Growth in cough, cold and allergy (hay fever) remedies in Tunisia is supported by a number of factors. Firstly, Tunisian consumers’ propensity to self-medicate for minor ailments, purchasing OTC products from pharmacists instead of seeking medical ...
Country Report
Nov 2020
Typically, sales of cough, cold and allergy (hay fever) remedies are highly dependent on the season as it is used to combat flu. Sales in 2020 were boosted due to fear of contracting COVID-19 as well as increasing desire to self-medicate due to ...
Country Report
Nov 2020
Similarly to analgesics, the impact of COVID-19 on cough, cold and allergy (hay fever) remedies was mostly felt during the first two months after the initial lockdown was announced and implemented on 18 March by local health authorities. During this ...
Country Report
Nov 2020
Cold, cough and allergy (hay fever) remedies are expected to register double-digit value growth in 2020, though not as high as value growth over the review period. However, a lot of value growth over the review period has been driven by inflationary ...
Our Passport market research database provides market context, competitor insight and future trends analysis to help you make clear, confident decisions.
Learn More